FDA approves rival for ‘female Viagra’ from Raleigh firm Sprout Pharmaceuticals
The US Food and Drug Administration approved a drug to return sexual desire to some women with low libido, the agency said Friday.
The move creates a rival for Addyi, the first such drug approved for women. It is made by Raleigh-based Sprout Pharmaceuticals and is known as the “female Viagra.”
The drug, bremelanotide, sold under the brand name Vyleesi by AMAG Pharmaceuticals, is an injection to be taken before sex. It’s intended to treat women who are premenopausal and have hypoactive sexual desire disorder, where a lack of interest in sex may cause significant distress in a woman’s life.
It will be available in September, and the company has not yet determined pricing or reimbursement information, according to AMAG spokeswoman Sarah Connors.
The US Food and Drug Administration approved a drug to return sexual desire to some women with low libido, the agency said Friday.
The move creates a rival for Addyi, the first such drug approved for women. It is made by Raleigh-based Sprout Pharmaceuticals and is known as the “female Viagra.”
The drug, bremelanotide, sold under the brand name Vyleesi by AMAG Pharmaceuticals, is an injection to be taken before sex. It’s intended to treat women who are premenopausal and have hypoactive sexual desire disorder, where a lack of interest in sex may cause significant distress in a woman’s life.
It will be available in September, and the company has not yet determined pricing or reimbursement information, according to AMAG spokeswoman Sarah Connors.
